Novartis has appointed Mike Ball as division head and chief executive officer of Alcon, effective Feb. 1, as part of its plan to strengthen the under-performing division. He succeeds Jeff George, who has decided to leave Novartis. Ball will also be a member of Novartis' executive committee. He joins Novartis ...

Buying a membership today will give you:
To continue reading this article register now.